Elevated at-risk auto-antibodies such as ATA associate with a very high frequency of SSc-ILD developing within the first 3 years of disease.[6] This is seen in both dcSSc and lcSSc with ATA reactivity.[6] Other antibodies also seem to give increased risk of this early phase of SSc-ILD. This evidence concerns the gene ATM and interstitial lung disease.